Horst Sievert
EDUCATION
1979 Medical Degree
1980 Doctorate MD, Johann Wolfgang Goethe University Frankfurt, Germany
1988 Board certified in Cardiology, Frankfurt, Germany
1990 State Doctorate, PhD, Johann Wolfgang Goethe University Frankfurt, Germany
1990 - 1993 Chief of Cardiology at Heart and Vascular Center Rotenburg an der Fulda, Germany
1993 - 2003 Senior Consultant at Cardiovascular Center Bethanien (CCB), Bethanien Hospital Frankfurt, Germany
Since 2003 Director CVC Frankfurt, St. Katharinen Hospital Frankfurt, Germany
ACTIVE AREAS OF RESEARCH
Director and Founder of CVC Frankfurt in 2003
Specialist in Internal Medicine, Cardiology, Angiology, and Intensive Care
Medical degree from Johannes Gutenberg University Mainz and Johann Wolfgang Goethe University Frankfurt, Germany
Declaration of interest
| Function | Company |
|---|---|
| Grants/research support | Abbott Vascular |
| Grants/research support | Access Closure |
| Grants/research support | AGA |
| Grants/research support | Arstasis |
| Grants/research support | Atritech |
| Grants/research support | Atrium |
| Grants/research support | Avinger |
| Grants/research support | Bard |
| Grants/research support | Boston Scientific |
| Grants/research support | Bridgepoint |
| Grants/research support | Cardiac Dimensions |
| Grants/research support | Cardiokinetix |
| Grants/research support | CardioMEMS |
| Grants/research support | Coherex |
| Grants/research support | Contego |
| Grants/research support | Cook Medical |
| Grants/research support | Cordis Cardiac & Vascular Institute |
Latest contributions
Academic Research Consortium initiative on left atrial appendage closure – standardising definitions and endpoints to move forward
21 May 2025
Philippe Garot describes the EuroPCR 2025 session on left atrial appendage closure (LAAC), which offers a preview of the upcoming new consensus document developed by the Academic Research Consortium.
Author
Academic Research Consortium on LAA closure
21 May 2025 – From EuroPCR 2025
Gain comprehensive understanding of the Academic Research Consortium's achievements in left atrial appendage (LAA) closure. Learn how standardized endpoints are streamlined for randomized controlled trials and how collaborative efforts homogenize definitions to advance clinical research.
Embolic protection, TAVI, heart failure and artificial intelligence: what's new in 2023
19 May 2023 – From EuroPCR 2023
This session covers various topics related to transcatheter aortic valve replacement, including the Protect Head-to-Head study on full-body embolic protection during TAVR, the FLOWer device for complete embolic protection, the use of a pulsing aspiration pump for percutaneous thrombectomy, and many more innovation updates from 2023.
EuroPCR 2021 Hotlines / Late-Breaking Trials: PLA-pCi-EBO-pilot, CALM, ISCHEMIA, and more!
26 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in stable CAD:
- Effects of visualization of PCI results on symptoms in chronic coronary syndrome
- Effect of Atorvastatin Therapy on Serial Changes of Coronary Flow And Plaque
- Initial results of a feasibility study of endovascular baroreflex amplification in heart failure patients
- Impact...
Interventional treatment for heart failure
18 May 2021 – From EuroPCR 2021
Watch this session if you want to learn about interventional techniques for monitoring and treatment of patients with heart failure and to review options for haemodynamic support in patients with acute heart failure.
This session was originally presented during EuroPCR 2021.
